Acura Pharmaceuticals Inc ACUR:Over The Counter Mkt

*Data is delayed | Exchange | USD
Last | 05/03/24 EDT
0.0041quote price arrow up+0.0011 (+36.6667%)
Volume
260
52 week range
0.00 - 0.05
Loading...
  • Open0.0041
  • Day High0.0041
  • Day Low0.0041
  • Prev Close0.003
  • 52 Week High0.05
  • 52 Week High Date04/16/24
  • 52 Week Low0.00
  • 52 Week Low Date12/22/23

Key Stats

  • Market Cap270,607.293
  • Shares Out66.00M
  • 10 Day Average Volume520
  • Dividend-
  • Dividend Yield-
  • Beta2.37
  • YTD % Change4,000

KEY STATS

  • Open0.0041
  • Day High0.0041
  • Day Low0.0041
  • Prev Close0.003
  • 52 Week High0.05
  • 52 Week High Date04/16/24
  • 52 Week Low0.00
  • 52 Week Low Date12/22/23
  • Market Cap270,607.293
  • Shares Out66.00M
  • 10 Day Average Volume520
  • Dividend-
  • Dividend Yield-
  • Beta2.37
  • YTD % Change4,000

RATIOS/PROFITABILITY

  • EPS (TTM)-0.02
  • P/E (TTM)-0.20
  • Fwd P/E (NTM)-0.03
  • EBITDA (TTM)-1.094M
  • ROE (TTM)13,209.72%
  • Revenue (TTM)1.563M
  • Gross Margin (TTM)4.20%
  • Net Margin (TTM)-56.24%
  • Debt To Equity (MRQ)112.36%

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Acura Pharmaceuticals Inc

 

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Acura Pharmaceuticals, Inc. is a drug delivery company engaged in the research, development, and commercialization of technologies and products to address the safe use of medications. Its platform technologies include LIMITX Technology, AVERSION Technology, and IMPEDE Technology. Its LIMITX Technology is designed to minimize the risks and side effects associated with overdose by retarding the release of active drug ingredients when too many tablets are accidentally or...
Robert Jones
President, Chief Executive Officer, Director
Peter Clemens
Chief Financial Officer, Senior Vice President, Secretary
Albert Brzeczko Ph.D.
Vice President - Pharmaceutical Sciences
Robert Seiser
Vice President, Corporate Controller, Treasurer
James Emigh
Vice President - Corporate Development
Address
616 N North Ct Ste 120
Palatine, IL
60067
United States

Top Peers

SYMBOLLASTCHG%CHG
TRVN
Trevena Inc
0.4126+0.0031+0.757%
EVOK
Evoke Pharma Inc
0.4855+0.0278+6.0738%
NAVB
Navidea Biopharmaceuticals Inc
0.0382+0.0033+9.2857%
GTBP
GT Biopharma Inc
3.29+0.10+2.97%
AVTX
Avalo Therapeutics Inc
14.36-1.03-6.69%